Table 4.
Analysis of the five SNPs based on additive, dominant, and recessive model.
| Gene | SNP | Allele | Group | Additive model | Dominant model | Recessive model | |||
|---|---|---|---|---|---|---|---|---|---|
| P c | OR (95% CI) | P c | OR (95% CI) | P c | OR (95% CI) | ||||
| TNFSF4 | rs2205960 | T | DM | NS | 1.00 (0.86–1.17) | NS | 0.98 (0.81–1.18) | NS | 1.09 (0.74–1.59) |
| PM | NS | 1.04 (0.86–1.26) | NS | 1.08 (0.86–1.36) | NS | 1.09 (0.74–1.59) | |||
| DM/PM | NS | 1.02 (0.89–1.16) | NS | 1.01 (0.86–1.20) | NS | 1.04 (0.74–1.46) | |||
|
| |||||||||
| TNFSF4 | rs844644 | C | DM | 0.830 | 1.10 (0.96–1.26) | 0.385 | 1.21 (0.98–1.48) | NS | 1.05 (0.83–1.33) |
| PM | NS | 1.05 (0.89–1.24) | NS | 1.14 (0.89–1.48) | NS | 1.05 (0.83–1.33) | |||
| DM/PM | 0.965 | 1.08 (0.96–1.22) | 0.340 | 1.18 (0.99–1.42) | NS | 1.02 (0.83–1.26) | |||
|
| |||||||||
| TNFSF4 | rs844648 | A | DM | NS | 1.08 (0.94–1.23) | 0.205 | 1.24 (1.01–1.53) | NS | 0.95 (0.75–1.20) |
| PM | NS | 1.05 (0.89–1.24) | 0.655 | 1.22 (0.94–1.58) | NS | 0.95 (0.75–1.20) | |||
| DM/PM | NS | 1.07 (0.95–1.20) | 0.115 | 1.24 (1.03–1.48) | NS | 0.93 (0.76–1.14) | |||
|
| |||||||||
| ANKRD55 | rs6859219 | A | DM | NS | 0.75 (0.27–2.12) | NS | 0.75 (0.27–2.12) | NA | NA |
| PM | NS | 1.36 (0.48–3.84) | NS | 1.36 (0.48–3.84) | NA | NA | |||
| DM/PM | NS | 0.97 (0.42–2.22) | NS | 0.97 (0.42–2.22) | NA | NA | |||
|
| |||||||||
| ANKRD55 | rs7731626 | A | DM | 0.135 | 0.76 (0.60–0.97) | 0.155 | 0.75 (0.58–0.97) | NS | 0.61 (0.22–1.67) |
| PM | 0.760 | 0.81 (0.60–1.08) | NS | 0.83 (0.61–1.14) | 0.700 | 0.61 (0.22–1.67) | |||
| DM/PM | 0.085 | 0.78 (0.63–0.96) | 0.145 | 0.78 (0.62–0.97) | 0.575 | 0.47 (0.18–1.20) | |||
SNPs = single nucleotide polymorphisms; Pc = P value corrected by Bonferroni method; OR = odds ratio; CI = confidence interval; DM = dermatomyositis; PM = polymyositis; NS = not significant; NA = not available.